Cor Vasa 2012, 54(9-10):517-519

Antikoagulační léčba dabigatranem a nová doporučení Evropské kardiologické společnosti pro management fibrilace síní

MUDr. Petr Janský
Kardiochirurgická klinika, 2. lékařská fakulta Univerzity Karlovy a Fakultní nemocnice Motol, Praha

Published: September 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Janský P. Antikoagulační léčba dabigatranem a nová doporučení Evropské kardiologické společnosti pro management fibrilace síní. Cor Vasa. 2012;54(9-10):517-519.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. J. Heeringa, D.A. van der Kuip, A. Hofman, et al., Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study, European Heart Journal 27 (2006) 949-953. Go to original source... Go to PubMed...
    2. H.J. Lin, P.A. Wolf, M. Kelly-Hayes, et al., Stroke severity in atrial fibrillation. The Framingham Study, Stroke 27 (1996) 1760-1764. Go to original source... Go to PubMed...
    3. R.G. Hart, L.A. Pearce, M.I. Aguilar, Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation, Annals of Internal Medicine 146 (2007) 857-867. Go to original source...
    4. S.J. Connolly, M.D. Ezekowitz, S. Yusuf, et al. Newly identified events in the RE-LY trial, New England Journal of Medicine 363 (2010) 1875-1876. Go to original source... Go to PubMed...
    5. S.H. Hohnloser, J. Oldgren, S. Yang, et al., Myocardial ischemic events in patients with atrial fibrillation treated with dabigatran or warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial, Circulation 125 (2012) 669-676. Go to original source... Go to PubMed...
    6. R. Nagarakanti, M.D. Ezekowitz, J. Oldgren, et al., Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion, Circulation 123 (2011) 131-136. Go to original source... Go to PubMed...
    7. A.J. Camm, G.Y. Lip, R. De Caterina, et al., 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation * Developed with the special contribution of the European Heart Rhythm Association, European Heart Journal 2012 Aug 24. [Epub ahead of print]

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes